MeSH tree: E02.774
From yoga studios to boutique gyms, workouts performed beneath infrared heating panels have become a visible fitness trend. Studios often claim that infrared heat improves circulation, flexibility and recovery, reduces inflammation ...
Jul 30, 2026
0
3
Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells. The treatment has become an important option for certain skin cancers because it can target diseased tissue ...
Jul 21, 2026
0
6
A research team led by Professor Yoosoo Yang (Department of Integrative Biotechnology) of Sungkyunkwan University, in collaboration with the Korea Institute of Science and Technology (KIST) and Incheon National University, ...
Jul 10, 2026
0
13
An anticancer medication called TLD1433, a ruthenium(II) complex that has entered Phase II trials for conditions such as non-muscle-invasive bladder cancer, is now being repurposed to address one of the biggest public health ...
A new implantable device which aims to maximize the effectiveness of light-sensitive drugs could improve outcomes for bladder cancer patients in the future. Engineers and cancer scientists from the University of Glasgow are ...
May 21, 2026
0
4
Researchers from the Universitat Politècnica de València, the Francesc de Borja University Hospital in Gandia and the La Ribera University Hospital, through the Fisabio Foundation, have found that sunlight passing through ...
Apr 15, 2026
0
6
Instead of applying ointment and attaching a bandage, a "smart patch that regulates treatment intensity on its own just by being attached" has appeared. A research team has developed a "self-regulating OLED wound healing ...
Apr 13, 2026
0
6
A rise of high-tech recovery culture is underway. As sports science becomes increasingly accessible, we're seeing a trickle-down effect from elite athletes to weekend warriors, and even recreational exercisers, who are exploring ...
Apr 10, 2026
0
11
Photodynamic treatment of cancer is based on administering an initially inactive substance that is only activated in the tumor via targeted light irradiation. It then generates reactive oxygen species that kill the cancer ...
Apr 7, 2026
0
10
The U.S. Food and Drug Administration has approved Johnson & Johnson's Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist, for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric ...
Mar 25, 2026
0
3
